Currently browsing: Items authored or edited by Perla Pucci

Waters, Ella; Pucci, Perla; Hirst, Mark; Chapman, Simon; Wang, Yuzhuo; Crea, Francesco and Heath, Christopher (2021). HAR1: an insight into lncRNA genetic evolution. Epigenomics, 13(22) pp. 1831–1843.

• Download Published Version (PDF / 1MB)

Mather, Rebecca L.; Parolia, Abhijit; Carson, Sandra E.; Venalainen, Erik; Roig-Carles, David; Jaber, Mustapha; Chu, Shih‐Chun; Alborelli, Ilaria; Wu, Rebecca; Lin, Dong; Nabavi, Noushin; Jachetti, Elena; Colombo, Mario P.; Xue, Hui; Pucci, Perla; Ci, Xinpei; Hawkes, Cheryl; Li, Yinglei; Pandha, Hardev; Ulitsky, Igor; Marconett, Crystal; Quagliata, Luca; Jiang, Wei; Romero, Ignacio A; Wang, Yuzhuo and Crea, Francesco (2021). The evolutionarily conserved long non‐coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms. Molecular Oncology, 15(7) pp. 1921–1941.

• Download Published Version (PDF / 2MB)

Latarani, Maryam; Pucci, Perla; Roig-Carles, David; Eccleston, Mark; Xue, Hui; Hawkes, Cheryl; Rigas, Sushila; Wang, Yuzhuo and Crea, Francesco (2020). EZH2 as a therapeutic target for aggressive prostate cancer. In: Crick Cancer Research Symposium, iPoster, 5-6 Oct 2020, The Francis Crick Institute and Virtual.

Pucci, Perla; Crea, Francesco; Alborelli, Ilaria; Quagliata, Luca; Bootman, Martin; Rigas, Sushilaben; Romero, Ignacio and Wang, Yuzhuo (2020). Long non-coding RNAs are key players in Prostate cancer tumorigenesis and drug resistance. In: 27th Annual PCF Scientific Retreat Virtual Poster Session, 20-23 Oct 2020, Virtual, Morressier.

• Download Research Poster (PDF / 515kB)

Pucci, Perla; Venalainen, Erik; Alborelli, Ilaria; Quagliata, Luca; Hawkes, Cheryl; Mather, Rebecca; Romero, Ignacio A; Rigas, Sushila; Wang, Yuzhuo and Crea, Francesco (2020). LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics, 12(13) pp. 1123–1138.

• Download Accepted Manuscript (PDF / 249kB)

Pucci, Perla (2020). The Mechanistic Role of Long Non-coding RNAs in Advanced Prostate Cancer Response to Therapy. PhD thesis The Open University.

• Download Final Version (PDF / 5MB)

Pucci, P.; Venalainen, E.; Alborelli, I.; Quagliata, L.; Mather, R.; Rigas, S.; Romero, I.; Wang, Y. and Crea, F. (2019). HORAS5 promotes cabazitaxel resistance in castration resistant prostate cancer via a BCL2A1-dependent survival mechanism. Annals of Oncology, 30(5) v798.

Silvestri, Roberto; Pucci, Perla; Venalainen, Erik; Matheou, Chrysanthi; Mather, Rebecca; Chandler, Stephen; Aceto, Romina; Rigas, Sushila; Wang, Yuzhuo; Rietdorf, Katja; Bootman, Martin and Crea, Francesco (2019). T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells. The Prostate, 79(13) pp. 1580–1586.

• Download Accepted Manuscript (PDF / 10MB)

Parolia, Abhijit; Venalainen, Erik; Xue, Hui; Mather, Rebecca; Lin, Dong; Wu, Rebecca; Pucci, Perla; Rogalski, Jason; Evans, Joseph; Feng, Felix; Collins, Colin; Wang, Yuzhuo and Crea, Francesco (2019). The long non-coding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Molecular Oncology, 13(5) pp. 1121–1136.

• Download Published Version (PDF / 1MB)

Pucci, Perla; Rescigno, Pasquale; Sumanasuriya, Semini; de Bono, Johann and Crea, Francesco (2018). Hypoxia and Noncoding RNAs in Taxane Resistance. Trends in Pharmacological Sciences, 39(8) pp. 695–709.

Mather, Rebecca L.; Venalainen, Erik; Pucci, Perla; Lin, Dong; Xue, Hui; Wang, Yuzhuo and Crea, Francesco (2017). The long non-coding RNA NEAR1 promotes neuroendocrine prostate cancer cell proliferation and survival. In: 3rd International Cancer Symposium, Cancer Research Center of Lyon (CRCL), 25-27 Sep 2017, Lyon, France.

Pucci, Perla; Venalainen, Erik; Mather, Rebecca; Xue, Hui; Rigas, Sushila; Romero, Ignacio A; Wang, Yuzho and Crea, Francesco (2017). Identification of a long non-coding RNA that mediates response to therapy in castration-resistant prostate cancer. In: 3rd International Cancer Symposium, 25-27 Sep 2017, Lyon, France.